Antitauon

Current research focuses on both to combat these tauon species: Example Agents / Trials Passive Immunotherapy

Using antisense oligonucleotides (ASOs) or "intrabodies" to reduce tau levels within the cell. antitauon

Stopping tau proteins from sticking together to form toxic seeds. Current research focuses on both to combat these

While many antitauon therapies have reached clinical trials, results have been mixed: antitauon

Promoting the removal of pathological tau via microglia or through intracellular degradation pathways like the proteasome. Key Therapeutic Strategies

In the context of neurodegenerative research, "antitauons" refer to or therapeutic agents designed to neutralize tauons —the prion-like, pathological forms of the tau protein that spread from neuron to neuron. Overview of Tauons and Antitauons

Using antibodies to bind to extracellular tau species, preventing them from being taken up by healthy neighboring neurons.